Dapagliflozin Related Products
Dapagliflozin is a sodium-glucose cotransporter 2 inhibitor used in the management of type 2 diabetes mellitus It is also used to treat adults with heart failure and chronic kidney disease.
Vsquare is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Dapagliflozin, pharmacopeial and non-pharmacopeial Dapagliflozin impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Dapagliflozin impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Dapagliflozin-related products are thoroughly characterized. Dapagliflozin products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.
Pharmaceutical Reference Standards
5-Methoxy Dapagliflozin Tetraacetate
| VS CAT No | : VS-D015127 |
| CAS No | : 2266576-17-2 |
| Mol.F. | : C29H31ClO11 |
| Mol.Wt. | : 591.0 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin
| VS CAT No | : VS-D015000 |
| CAS No | : 461432-26-8 |
| Mol.F. | : C21H25CIO6 |
| Mol.Wt. | : 408.9 |
| Inv. Status | : Custom Synthesis |
| Rel. CAS No | : 960404-48-2 (Propandiol Hydrate) ; 1971128-01-4 (Propanediol) |
Dapagliflozin Allose Isomer
| VS CAT No | : VS-D015057 |
| CAS No | : 1888296-95-4 |
| Mol.F. | : C21H25ClO6 |
| Mol.Wt. | : 408.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Bromo Impurity
| VS CAT No | : VS-D015007 |
| CAS No | : 461432-23-5 |
| Mol.F. | : C15H14BrClO |
| Mol.Wt. | : 325.6 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Bromomethanone
| VS CAT No | : VS-D015029 |
| CAS No | : 461432-22-4 |
| Mol.F. | : C15H12BrClO2 |
| Mol.Wt. | : 339.6 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Citrate
| VS CAT No | : VS-D015088 |
| CAS No | : 1848226-91-4 |
| Mol.F. | : C21H25ClO6 : C6H8O7 |
| Mol.Wt. | : 408.9 : 192.1 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Deschloro Impurity
| VS CAT No | : VS-D015003 |
| CAS No | : 2444702-80-9 |
| Mol.F. | : C21H26O6 |
| Mol.Wt. | : 374.4 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Dibromo Compound
| VS CAT No | : VS-D015015 |
| CAS No | : 1807632-93-4 |
| Mol.F. | : C15H14Br2O |
| Mol.Wt. | : 370.1 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Diproline
| VS CAT No | : VS-D015109 |
| CAS No | : 960404-62-0 |
| Mol.F. | : C21H25ClO6 : 2(C5H9NO2) |
| Mol.Wt. | : 408.9 : 2(115.1) |
| Inv. Status | : Custom Synthesis |
| Rel. CAS No | : 461432-26-8 (free base) ; 960404-48-2 (Propandiol Hydrate) ; 1971128-01-4 (Propanediol) |
Dapagliflozin EP Impurity A
| VS CAT No | : VS-D015001 |
| CAS No | : 1807632-95-6 |
| Mol.F. | : C21H25BrO6 |
| Mol.Wt. | : 453.3 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin EP Impurity B
| VS CAT No | : VS-D015049 |
| CAS No | : NA |
| Mol.F. | : C23H29ClO6 |
| Mol.Wt. | : 436.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Furanose Isomer
| VS CAT No | : VS-D015031 |
| CAS No | : 1469910-70-0 |
| Mol.F. | : C21H25ClO6 |
| Mol.Wt. | : 408.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Galacto Isomer
| VS CAT No | : VS-D015058 |
| CAS No | : 1408245-02-2 |
| Mol.F. | : C21H25ClO6 |
| Mol.Wt. | : 408.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Hydroxy Impurity
| VS CAT No | : VS-D015032 |
| CAS No | : 960404-86-8 |
| Mol.F. | : C21H25ClO7 |
| Mol.Wt. | : 424.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Imp.-S2E (Tri acetylated)
| VS CAT No | : VS-D015040 |
| CAS No | : 1443341-94-3 |
| Mol.F. | : C27H31ClO9 |
| Mol.Wt. | : 535.0 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 1
| VS CAT No | : VS-D015006 |
| CAS No | : 1103738-29-9 |
| Mol.F. | : C15H14ClIO |
| Mol.Wt. | : 372.6 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 14
| VS CAT No | : VS-D015023 |
| CAS No | : 1830346-16-1 |
| Mol.F. | : C15H14BrClO |
| Mol.Wt. | : 325.6 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 17
| VS CAT No | : VS-D015026 |
| CAS No | : 2133407-75-5 |
| Mol.F. | : C21H25ClO6 |
| Mol.Wt. | : 408.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 18
| VS CAT No | : VS-D015028 |
| CAS No | : NA |
| Mol.F. | : C21H25ClO6 |
| Mol.Wt. | : 408.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 19
| VS CAT No | : VS-D015033 |
| CAS No | : 2133407-73-3 |
| Mol.F. | : C18H23ClOSi |
| Mol.Wt. | : 318.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 2
| VS CAT No | : VS-D015011 |
| CAS No | : 1280647-32-6 |
| Mol.F. | : C15H14BrClO2 |
| Mol.Wt. | : 341.6 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 23
| VS CAT No | : VS-D015043 |
| CAS No | : 2452300-78-4 |
| Mol.F. | : C42H48Cl2O12 |
| Mol.Wt. | : 815.7 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 29
| VS CAT No | : VS-D015051 |
| CAS No | : 1415905-91-7 |
| Mol.F. | : C27H31ClO9 |
| Mol.Wt. | : 535.0 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 31
| VS CAT No | : VS-D015053 |
| CAS No | : 2069934-29-6 |
| Mol.F. | : C15H14Cl2O |
| Mol.Wt. | : 281.2 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 38
| VS CAT No | : VS-D015062 |
| CAS No | : 526-95-4 |
| Mol.F. | : C6H12O7 |
| Mol.Wt. | : 196.2 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 39
| VS CAT No | : VS-D015063 |
| CAS No | : 864070-18-8 |
| Mol.F. | : C13H10BrClO |
| Mol.Wt. | : 297.6 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 4
| VS CAT No | : VS-D015009 |
| CAS No | : 461432-24-6 |
| Mol.F. | : C22H27ClO7 |
| Mol.Wt. | : 438.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 40
| VS CAT No | : VS-D015064 |
| CAS No | : 29643-62-7 |
| Mol.F. | : C10H14O |
| Mol.Wt. | : 150.2 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 41
| VS CAT No | : VS-D015066 |
| CAS No | : 66534-31-4 |
| Mol.F. | : C13H11ClO |
| Mol.Wt. | : 218.7 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 5
| VS CAT No | : VS-D015014 |
| CAS No | : NA |
| Mol.F. | : C21H25BrO6 |
| Mol.Wt. | : 453.3 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 63
| VS CAT No | : VS-D015090 |
| CAS No | : 2173339-31-4 |
| Mol.F. | : C23H29ClO7 |
| Mol.Wt. | : 452.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 85
| VS CAT No | : VS-D015121 |
| CAS No | : NA |
| Mol.F. | : C27H31ClO9 |
| Mol.Wt. | : 535.0 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 9
| VS CAT No | : VS-D015018 |
| CAS No | : NA |
| Mol.F. | : C21H27ClO7 |
| Mol.Wt. | : 426.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 97
| VS CAT No | : VS-D015135 |
| CAS No | : NA |
| Mol.F. | : C21H23ClO6 |
| Mol.Wt. | : 406.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity 99
| VS CAT No | : VS-D015137 |
| CAS No | : 2271248-78-1 |
| Mol.F. | : C21H25ClO6 |
| Mol.Wt. | : 408.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity B
| VS CAT No | : VS-D015008 |
| CAS No | : 1662702-90-0 |
| Mol.F. | : C15H15ClO |
| Mol.Wt. | : 246.7 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Impurity D
| VS CAT No | : VS-D015010 |
| CAS No | : 1373321-04-0 |
| Mol.F. | : C21H25ClO6 |
| Mol.Wt. | : 408.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Methoxy Pyranose Impurity
| VS CAT No | : VS-D015004 |
| CAS No | : 714269-57-5 |
| Mol.F. | : C22H27ClO7 |
| Mol.Wt. | : 438.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Ortho Isomer
| VS CAT No | : VS-D015027 |
| CAS No | : 2040305-05-1 |
| Mol.F. | : C21H25ClO6 |
| Mol.Wt. | : 408.9 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin Propanediol Monohydrate
| VS CAT No | : VS-D015045 |
| CAS No | : 960404-48-2 |
| Mol.F. | : C21H25ClO6 : C3H8O2 : H2O |
| Mol.Wt. | : 408.9 : 76.1 : 18.0 |
| Inv. Status | : Custom Synthesis |
| Rel. CAS No | : 461432-26-8 (free base) ; 1971128-01-4 (Propanediol) |
Dapagliflozin Tetraacetate
| VS CAT No | : VS-D015005 |
| CAS No | : 461432-25-7 |
| Mol.F. | : C29H33ClO10 |
| Mol.Wt. | : 577.0 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin TNG
| VS CAT No | : VS-D015030 |
| CAS No | : 714269-58-6 |
| Mol.F. | : C30H35ClO11 |
| Mol.Wt. | : 607.1 |
| Inv. Status | : Custom Synthesis |
Dapagliflozin-(R)-Furanose
| VS CAT No | : VS-D015042 |
| CAS No | : 1469910-83-5 |
| Mol.F. | : C21H25ClO6 |
| Mol.Wt. | : 408.9 |
| Inv. Status | : Custom Synthesis |
Hydroxy Dapagliflozin (USP)
| VS CAT No | : VS-D015021 |
| CAS No | : 1204222-85-4 |
| Mol.F. | : C21H25ClO7 |
| Mol.Wt. | : 424.9 |
| Inv. Status | : Custom Synthesis |
MonoAcetyl Dapagliflozin
| VS CAT No | : VS-D015035 |
| CAS No | : 1632287-34-3 |
| Mol.F. | : C23H27ClO7 |
| Mol.Wt. | : 450.9 |
| Inv. Status | : Custom Synthesis |
O-Desethyl Dapagliflozin
| VS CAT No | : VS-D015022 |
| CAS No | : 864070-37-1 |
| Mol.F. | : C19H21ClO6 |
| Mol.Wt. | : 380.8 |
| Inv. Status | : Custom Synthesis |
O-Pentaacetyl O-Desethyl Dapagliflozin
| VS CAT No | : VS-D015054 |
| CAS No | : 912917-85-2 |
| Mol.F. | : C29H31ClO11 |
| Mol.Wt. | : 591.0 |
| Inv. Status | : Custom Synthesis |
Oxo Dapagliflozin (USP)
| VS CAT No | : VS-D015024 |
| CAS No | : 2169998-23-4 |
| Mol.F. | : C21H23ClO7 |
| Mol.Wt. | : 422.9 |
| Inv. Status | : Custom Synthesis |